Ozempic vs Wegovy: same drug, different label

Key takeaways

• Ozempic and Wegovy are the same molecule: semaglutide, made by Novo Nordisk, taken as a once-weekly injection under the skin. The difference is the brand on the box .
• The labels differ. Ozempic is FDA-approved for type 2 diabetes blood-sugar control, and separately to lower heart and kidney risk in people who have diabetes. Wegovy is approved for weight management, and separately to lower heart risk in people with heart disease .
• The top dose differs. Ozempic tops out at 2 mg once weekly; Wegovy climbs higher, to a 2.4 mg maintenance dose, with a 7.2 mg option now approved for more weight loss .
• That higher dose is why Wegovy is the weight-loss brand: at 2.4 mg, semaglutide cut body weight by about 14.9 percent versus 2.4 percent on placebo over 68 weeks in the STEP-1 trial .
• Coverage follows the label, not the molecule. Because Ozempic is labeled for diabetes and Wegovy for weight, insurers treat them as different products, so the identical semaglutide can be covered under one name and denied under the other .

Same molecule, two labels: the side by side

Why they are genuinely the same drug

Semaglutide is a GLP-1 receptor agonist, a drug that mimics a gut hormone your body already makes to blunt appetite and steady blood sugar. The molecule inside an Ozempic pen and the molecule inside a Wegovy pen are the same semaglutide, from the same company .

The two names exist because Novo Nordisk took semaglutide to the FDA on two separate tracks. Ozempic was approved first, for type 2 diabetes. Wegovy came later, at a higher dose, for weight management. The packaging and the approved use are what differ. The semaglutide is identical. When people say the two are different drugs, this is the part they get wrong.

Wegovy's higher dose is the real practical difference

Ozempic's doses were set for controlling blood sugar, and it stops at 2 mg once weekly . Wegovy was built to push weight loss further, so it climbs to a 2.4 mg maintenance dose, and a 7.2 mg option was later added for people who need more . It is the same drug, just at a higher dose.

That higher dose is the whole reason Wegovy is the weight-loss brand. In STEP-1, the trial behind the 2.4 mg dose, adults with obesity lost about 14.9 percent of their body weight over 68 weeks, versus about 2.4 percent on placebo . Ozempic causes weight loss too, because it is the same drug, but it was not studied or dosed for that job.

Because it is one molecule, the side effects are the same family too, mostly gut ones like nausea and constipation, and they tend to track the dose. For what tends to help with those, see GLP-1 side effects and what actually helps.

The questions people actually search

Are they the same drug? Yes. Both are semaglutide from Novo Nordisk, the same pen, the same weekly schedule . What differs is the label.

Can you use Ozempic for weight loss? It is the same drug, so it produces the same appetite drop and weight loss. But Ozempic is not FDA-approved for weight management, so using it for weight alone is off-label . That is common, but off-label is a different thing for coverage and for what a prescriber can put on paper. The version approved and dosed for weight is Wegovy .

Why is one covered and the other not? Insurers decide coverage by the approved use on the label, not by the molecule. So the identical semaglutide can be covered as Ozempic (a diabetes drug) and excluded as Wegovy (a weight-loss drug) under a plan that pays for one category but not the other .

One more mix-up worth clearing: Rybelsus. It is also semaglutide, but it is a daily pill approved for type 2 diabetes, in lower 3, 7, or 14 mg doses, not for weight loss . And it is not the same as the newer Wegovy pill, which is a higher 25 mg daily tablet approved for weight . For the pill-versus-pill details, see the Wegovy pill explainer.

The bottom line

Ozempic and Wegovy are the same drug, semaglutide, from the same maker, in the same weekly injection. The difference is the label: Ozempic for type 2 diabetes (plus heart and kidney risk in diabetes), Wegovy for weight (plus heart risk, plus MASH under an accelerated approval), with Wegovy dosed higher . That label difference is what sets the dose ceiling, the price, and what your insurance will do.

So when someone says Ozempic and Wegovy are different, they are half right. The box, the approved use, and the top dose are different. The molecule is the same.

For research and educational purposes only. Not medical advice.

pepSmart has not commissioned independent clinical review of this article.

More on how we write and source these pieces: Editorial process and contributor disclosure and Sourcing posture.

Spot an error? Email corrections via /about.

Sources: 6 entries, all primary canon (the FDA prescribing labels for Ozempic, Wegovy, and Rybelsus via DailyMed, plus the STEP-1, SELECT, and FLOW trials via PubMed), last reviewed 2026-07-13.

Related tools

• Tirzepatide dose calculator - Run tirzepatide-focused vial draw math.
• GLP-1 conversion calculator - Convert a GLP-1 mg dose to U-100 units and ml.
• GLP-1 ramp planner - Preview a linear educational dose-step table.
• Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
• PK simulator overview - Public overview of the Pro pharmacokinetic simulator.
• Semaglutide dose calculator - Run semaglutide-focused vial draw math.